Cardiac catheterization access site blood draw (qualitative coagulation assessment)
This test checks for bleeding or clotting issues at the site where a catheter was inserted into your heart.
["It helps ensure your body is healing properly after the procedure."]
Key facts at a glance
- LOINC
- 80243-9
- Short code
- CATHACC
- Synonyms
- Cardiac cath access site
- Category
- chemistry
- Sample
- serum
- Container
- Not applicable - clinical observation of vascular access site
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- ≥ 18 years
- Method
- Clinical observation; physical examination of vascular access site post-cardiac catheterization
- SNOMED
- 433112001
- Specimen volume
- 5 mL
- Stability
- Clinical assessment should be performed immediately post-procedure and monitored continuously during the recovery period per institutional protocol
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 4–24 hours
- Order
- routine
Why This Test Is Done
Your doctor may order this test if you experienced unusual bleeding, bruising, or signs of infection at the catheter insertion site after a cardiac catheterization. It helps monitor whether your blood is clotting normally or if there’s a risk of complications like excessive bleeding or clots forming at the access point.
What to Expect Before the Test
You’ll likely have a blood sample taken from the same site where the catheter was inserted, often under sterile conditions. The test may involve checking for specific markers that indicate clotting activity or bleeding tendencies, though results are qualitative (qualitative assessment rather than a measured value).
What the Test Measures
This test evaluates coagulation function at the access site, often using qualitative methods to detect abnormal bleeding or clotting tendencies. It may assess factors like platelet function, fibrin formation, or other markers related to hemostasis (blood clotting).
Preparation and Care
No special preparation is needed, but follow your doctor’s instructions regarding medications or activity restrictions. Keep the access site clean and dry, and avoid putting pressure on it. Report any signs of infection (redness, swelling, pain, or unusual discharge) or excessive bleeding immediately.
Reference range
No active bleeding, hematoma, or signs of infection at access site; intact hemostasis; normal distal perfusion; no pseudoaneurysm or arteriovenous fistulaN/A
No fasting required. Patient should remain supine with affected limb immobilized per institutional protocol post-procedure. Access site should be monitored at regular intervals per clinical team orders.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
This test helps identify potential complications after cardiac catheterization, such as delayed clotting (leading to bleeding) or premature clot formation (risking blockages). Early detection allows for prompt medical intervention if needed, improving recovery outcomes.
Frequently asked questions
Will this test show if I’m at risk for blood clots elsewhere in my body?
How long will it take to get results?
Can I drink or eat before this test?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy